BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21894381)

  • 1. Dengue-2 and yellow fever 17DD viruses infect human dendritic cells, resulting in an induction of activation markers, cytokines and chemokines and secretion of different TNF-α and IFN-α profiles.
    Gandini M; Reis SR; Torrentes-Carvalho A; Azeredo EL; Freire Mda S; Galler R; Kubelka CF
    Mem Inst Oswaldo Cruz; 2011 Aug; 106(5):594-605. PubMed ID: 21894381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.
    Liang H; Lee M; Jin X
    Cell Mol Immunol; 2016 Jan; 13(1):36-46. PubMed ID: 26435066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune responses in human dendritic cells upon infection by chimeric yellow-fever dengue vaccine serotypes 1-4.
    Deauvieau F; Sanchez V; Balas C; Kennel A; DE Montfort A; Lang J; Guy B
    Am J Trop Med Hyg; 2007 Jan; 76(1):144-54. PubMed ID: 17255244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects.
    Guy B; Nougarede N; Begue S; Sanchez V; Souag N; Carre M; Chambonneau L; Morrisson DN; Shaw D; Qiao M; Dumas R; Lang J; Forrat R
    Vaccine; 2008 Oct; 26(45):5712-21. PubMed ID: 18762226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis.
    Libraty DH; Pichyangkul S; Ajariyakhajorn C; Endy TP; Ennis FA
    J Virol; 2001 Apr; 75(8):3501-8. PubMed ID: 11264339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited replication of yellow fever 17DD and 17D-Dengue recombinant viruses in rhesus monkeys.
    Trindade GF; Marchevsky RS; Fillipis AM; Nogueira RM; Bonaldo MC; Acero PC; Caride E; Freire MS; Galler R
    An Acad Bras Cienc; 2008 Jun; 80(2):311-21. PubMed ID: 18506257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Answer to the review from Halstead and Russell "Protective and immunological behavior of chimeric yellow fever dengue vaccine" (DOI 10.1016/j.vaccine.2016.02.004).
    Hadinegoro SR; Arredondo-García JL; Guy B; Bouckenooghe A; Noriega F; Jackson N
    Vaccine; 2016 Aug; 34(36):4273-4. PubMed ID: 27452651
    [No Abstract]   [Full Text] [Related]  

  • 8. Human Schwann cells are susceptible to infection with Zika and yellow fever viruses, but not dengue virus.
    Dhiman G; Abraham R; Griffin DE
    Sci Rep; 2019 Jul; 9(1):9951. PubMed ID: 31289325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavivirus-Mediating B Cell Differentiation Into Antibody-Secreting Cells in Humans Is Associated With the Activation of the Tryptophan Metabolism.
    Bonezi V; Cataneo AHD; Branquinho MSF; Silva MBB; Gonzalez-Dias P; Pereira SS; Ferreira LCS; Nakaya HI; Campa A; Wowk PF; Silveira ELV
    Front Immunol; 2020; 11():20. PubMed ID: 32117223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules.
    Costa VV; Ye W; Chen Q; Teixeira MM; Preiser P; Ooi EE; Chen J
    mBio; 2017 Aug; 8(4):. PubMed ID: 28765218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RIG-I-like Receptor Triggering by Dengue Virus Drives Dendritic Cell Immune Activation and T
    Sprokholt JK; Kaptein TM; van Hamme JL; Overmars RJ; Gringhuis SI; Geijtenbeek TBH
    J Immunol; 2017 Jun; 198(12):4764-4771. PubMed ID: 28507028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T Cells.
    Cong Y; McArthur MA; Cohen M; Jahrling PB; Janosko KB; Josleyn N; Kang K; Zhang T; Holbrook MR
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004709. PubMed ID: 27191161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells.
    Palmer DR; Fernandez S; Bisbing J; Peachman KK; Rao M; Barvir D; Gunther V; Burgess T; Kohno Y; Padmanabhan R; Sun W
    J Gen Virol; 2007 Jan; 88(Pt 1):148-156. PubMed ID: 17170447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.
    Guirakhoo F; Kitchener S; Morrison D; Forrat R; McCarthy K; Nichols R; Yoksan S; Duan X; Ermak TH; Kanesa-Thasan N; Bedford P; Lang J; Quentin-Millet MJ; Monath TP
    Hum Vaccin; 2006; 2(2):60-7. PubMed ID: 17012873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes.
    Barba-Spaeth G; Longman RS; Albert ML; Rice CM
    J Exp Med; 2005 Nov; 202(9):1179-84. PubMed ID: 16260489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive TLR7 signaling, type I IFN production, and attenuated innate and adaptive immune responses to yellow fever virus in a primate reservoir host.
    Mandl JN; Akondy R; Lawson B; Kozyr N; Staprans SI; Ahmed R; Feinberg MB
    J Immunol; 2011 Jun; 186(11):6406-16. PubMed ID: 21515797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection
    Douam F; Soto Albrecht YE; Hrebikova G; Sadimin E; Davidson C; Kotenko SV; Ploss A
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17DD and 17D-213/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children.
    Campi-Azevedo AC; de Araújo-Porto LP; Luiza-Silva M; Batista MA; Martins MA; Sathler-Avelar R; da Silveira-Lemos D; Camacho LA; de Menezes Martins R; de Lourdes de Sousa Maia M; Farias RH; da Silva Freire M; Galler R; Homma A; Ribeiro JG; Lemos JA; Auxiliadora-Martins M; Caldas IR; Elói-Santos SM; Teixeira-Carvalho A; Martins-Filho OA
    PLoS One; 2012; 7(12):e49828. PubMed ID: 23251351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Infections of Zika, Dengue, and Yellow Fever Viruses in Human Cytotrophoblast-Derived Cells Suggest a Gating Role for the Cytotrophoblast in Zika Virus Placental Invasion.
    Viettri M; Caraballo G; Sanchez ME; Espejel-Nuñez A; Betanzos A; Ortiz-Navarrete V; Estrada-Gutierrez G; Nava P; Ludert JE
    Microbiol Spectr; 2023 Jun; 11(3):e0063023. PubMed ID: 37227282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.